The emergency authorization will allow a third dose of the Pfizer-BioNTech vaccine to be given to people over 65, healthcare workers, and others at high risk of severe COVID-19.
a booster dose of the Pfizer-BioNTech COVID-19 vaccine on Wednesday for older Americans, healthcare workers, and others at serious risk of severe cases, following tense debates over whether additional shots were needed.supporting Pfizer boosters for those groups, whom they argued would clearly benefit from increased immunity. The panel overwhelmingly rejected giving the boosters to all individuals 16 and older, citing the need for more safety data in younger age groups.
"After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others,” acting FDA Commissioner Janet WoodcockSome experts believe this wording on at-risk occupations...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And OlderPfizer said a third shot would restore the effectiveness of its COVID-19 vaccine to about 95%.
Read more »
FDA Officially Approves Pfizer Booster For 65 & Up, High Risk Categories; 3rd Shot For Others Still On Ice – UpdateUPDATE, 5:08 PM: Less than a week after an advisory panel to Food and Drug Administration rejected an application for wide-spread booster shots of of Pfizer’s Covid-19 vaccine, but gave the thumbs…
Read more »
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe FDA authorized Pfizer booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.
Read more »
Smaller COVID vaccine doses may protect children as well as full doses in adults: PfizerPfizer just released its first safety data about COVID-19 vaccines for children ages 5 to 11, reassuring parents that a safe and effective vaccine soon could be available for those younger than 12.
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Read more »